Preclinical translational imaging, and specifically molecular imaging methods such as positron emission tomography (PET) or single photon emission computed tomography (SPECT) as well as magnetic resonance imaging (MRI) are extremely useful tools in the drug discovery and development process. Continuous progress in modern imaging technologies holds a great potential to extend efficiencies to drug discovery and translation and to reduce clinical attrition. Newer technologies such as photoacoustic tomography and confocal laser endomicroscopy lend the ability to identify critical and highly specific biomarker information for oncology, neurology, and immunology strategies. These approaches can significantly enhance preclinical and translational research. The discussion will provide an overview of the strengths of different imaging technologies and will focus on scientific translational applications in oncology, neurology, immunology, and safety.
Animal Research
Animal Models
Life Science
Animal Sciences
Animal Behavior
Cancer
Veterinary Sciences
Research
Research And Development
Cell
Immunology
Cancer Research
Brain
Biology
Health
Europe84%
North America13%
Website Visitors97%
Post Doc25%
Research Scientist25%
Medical Doctor/Specialist13%
Executive8%
Biologist8%
Medical Laboratory Technician8%
Student4%
Facility/Department Manager4%
Scientist4%
Academic Institution52%
Hospital19%
Research Institute6%
Medical Center6%
Contract Research Organization (Cro)3%
Non-Profit Organization3%
Pharmaceutical Company3%
Biotech Company3%